Analysis of molecular profiling of renal cell carcinoma: Identification of a 4-microRNA signature as a prognostic value in patients with stage I-II disease.

Authors

Daniel E. Castellano

Uro-Oncology Unit, 12 de Octubre Universitary Hospital, Madrid, Spain

Daniel E. Castellano , Carlos A. Farfán , Gamez Angelo , Juan M. Sepúlveda , Guillermo De Velasco , Felipe Villacampa , Angel Tejido , Mario Dominguez , Federico de la Rosa , Juan A. Fresno

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 395)

DOI

10.1200/jco.2013.31.6_suppl.395

Abstract #

395

Poster Bd #

D16

Abstract Disclosures

FEATURED

Analysis of molecular profiling of renal cell carcinoma: Identification of a 4-microRNA signature as a prognostic value in patients with stage I-II disease.

Authors

Daniel E. Castellano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Poster Details

Meeting

Session Type

Session Title

Track

Sub Track

Citation

DOI

Abstract #

Poster Bd #

Similar Posters

Poster

Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC).

Poster

Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.

Poster

A novel pathological finding, "BABA", for a prognostic factor in oral tongue carcinoma.

Poster

Adjuvant pembrolizumab (pembro) for renal cell carcinoma (RCC) across UCLA Integrated Staging System (UISS) risk groups and disease stage: Subgroup analyses from the KEYNOTE-564 study.